Cargando…
CD4 responses against IDO
Natural indoleamine-2,3-dioxygenase (IDO)-reactive CD4(+) T cells have been shown to release interferonγ (IFNγ), tumor necrosis factor α (TNFα), as well as interleukin 17 (IL-17). In some individuals, these cells also demonstrated the ability to suppress IL-10 production. IDO-specific CD4(+) helper...
Autor principal: | Andersen, Mads Hald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494649/ https://www.ncbi.nlm.nih.gov/pubmed/23170283 http://dx.doi.org/10.4161/onci.20780 |
Ejemplares similares
-
FOXP3-specific immunity
por: Andersen, Mads Hald
Publicado: (2013) -
A road less traveled paved by IDO silencing: Harnessing the antitumor activity of neutrophils
por: Manuel, Edwin R., et al.
Publicado: (2013) -
Expression profile of the human IDO1 protein, a cancer drug target involved in tumoral immune resistance
por: Vigneron, Nathalie, et al.
Publicado: (2015) -
CD4(+) T cell plasticity engenders robust immunity in response to cytokine therapy
por: Nelles, Megan E, et al.
Publicado: (2015) -
Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?
por: Godet, Yann, et al.
Publicado: (2012)